Table 2 Adrenal and testicular function after cortrosyn and hCG stimulation obtained at 8 months
From: Undervirilized male infant with in utero exposure to maternal use of high dose antifungal therapy
| CORTROSYN STIMULATION TEST (250 mcg) | Reference value | Baseline | Stimulated (1 h) |
| ACTH (pg/ml) | 6–48 | 11 | |
| Cortisol (mcg/dl) | 2.8–23 | 19 | 29 |
| Aldosterone (ng/dl) | 5–90 | 38 | |
| Renin (ng/ml/hr) | 2–37 | 7.8 | |
| 17-Hydroxypregnenolone (ng/dl) | 42–540 | 528 | 1150 |
| 17-Hydroxyprogesterone (ng/dl) | < 91 | 57 | 182 |
| Androstenedione (ng/dl) | < 10–37 | < 10 | < 10 |
| DHEA (ng/dl) | < 136 | 78 | 114 |
| Testosterone (ng/dl) | < 2.5–10 | 3.6 | 3.8 |
| Dihydrotestosterone (ng/dl) | < 3 | 1.4 | |
| Corticosterone (ng/dl) | 80–1500 | 871 | |
| Deoxycorticosterone (ng/dl) | 7–49 | 15 | 43 |
| 11-Deoxycortisol (ng/dl) | < 10–156 | 54 | 107 |
| Estrone (pg/ml) | < 15 | < 2.5 | 6 |
| Progesterone (ng/dl) | < 10–15 | < 10 | 52 |
| hCG STIMULATION TEST (15,000 IU over 3 days) | Baseline | Day 4 | |
| LH (mIU/ml) | 0.02–7 | 0.228 | |
| FSH (mIU/ml) | 0.16–4.1 | 1.3 | |
| Testosterone (ng/dl) | < 2.5–10 | 3.6 | 587 |
| Dihydrotestosterone (ng/dl) | < 3 | 1.4 | 111 |
| Androstenedione (ng/dl) | < 10–37 | < 10 | 15 |
| Estrone (pg/ml) | < 15 | < 2.5 | 3.8 |
| Estradiol (pg/ml) | < 15 | < 1 | 1.5 |